Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

NCT00880854 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Bladder Cancer

Interventions

DRUG: BCG and CP-675,206

Sponsor

University of Wisconsin, Madison

Collaborators

[object Object]